FDA Alignment Boosts Wet AMD Treatment Path

• July 7, 2026

Artificial Intelligence in the Ophthalmic ASC

AI offers meaningful opportunities to improve efficiency in ophthalmic ASC coding and revenue cycle workflows, but accurate reimbursement still depends on structured review and oversight.

• by Matthew Baugh, MHA, COT, OCS, OCSR

• July 1, 2026

• 7 min

Assessing retina-specific ophthalmic counseling generated by an early public large language model across different levels of clinical urgency

• by Dominic M. Choo, Tyler A. Durham, Kishan G. Patel

• July 1, 2026

The retinal nerve fibre layer thickness slope: a localised biomarker of the structure–function relationship in early glaucoma

• by Stefan Steiner, Florian Frommlet, Florian Schwarzhans, Georg Fischer, Maximilian Pirrung, Michael Pircher, Christoph Hitzenberger, Clemens Vass

• July 1, 2026